Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Tetra Discovery Partners”

11 pharma patents match "Tetra Discovery Partners" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 11
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 11 pharmaceutical patents matching "Tetra Discovery Partners" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

11 results for “Tetra Discovery Partners” · 30,257 patents in full index Clear search

  1. US 12264169

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted

  2. US 11767334

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted

  3. US 11401286

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  4. US 11104660

    PDE4D inhibitors

    Tetra Discovery Partners · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted

  5. US 11028050

    Salts and polymorphs of a PDE4 inhibitor

    Tetra Discovery Partners · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  6. US 10626129

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  7. US 10364258

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  8. US 10093686

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  9. US 9777024

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted

  10. US 9221843

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted

  11. US 8865723

    Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury

    Tetra Discovery Partners · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.